Williams T - Search Results

1

Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.

John NA, Solanky BS, De Angelis F, Parker RA, Weir CJ, Stutters J, Carrasco FP, Schneider T, Doshi A, Calvi A, Williams T, Plantone D, Monteverdi A, MacManus D, Marshall I, Barkhof F, Gandini Wheeler-Kingshott CAM, Chataway J; MS‐SMART Investigators. John NA, et al. Among authors: williams t. J Magn Reson Imaging. 2024 Jun;59(6):2192-2201. doi: 10.1002/jmri.29017. Epub 2023 Oct 3. J Magn Reson Imaging. 2024. PMID: 37787109 Clinical Trial.

2

Immune-mediated encephalitis with daclizumab: The final nail.

Williams T, Chataway J. Williams T, et al. Mult Scler. 2019 Apr;25(5):753-754. doi: 10.1177/1352458518791374. Epub 2018 Aug 3. Mult Scler. 2019. PMID: 30073908

3

How to diagnose difficult white matter disorders.

Williams T, Houlden H, Murphy E, John N, Fox NC, Schott JM, Adams M, Davagananam I, Chataway J, Lynch DS. Williams T, et al. Pract Neurol. 2020 Aug;20(4):280-286. doi: 10.1136/practneurol-2020-002530. Epub 2020 May 20. Pract Neurol. 2020. PMID: 32434903 Review.

4

Neurofilaments in progressive multiple sclerosis: a systematic review.

Williams T, Zetterberg H, Chataway J. Williams T, et al. J Neurol. 2021 Sep;268(9):3212-3222. doi: 10.1007/s00415-020-09917-x. Epub 2020 May 23. J Neurol. 2021. PMID: 32447549 Free PMC article. Review.

5

The contemporary role of MRI in the monitoring and management of people with multiple sclerosis in the UK.

Fernandes L, Allen CM, Williams T, Tallantyre E, Evangelou N, Chataway J, Ford HL; UK MS Trials and Registries Consortium investigators. Fernandes L, et al. Among authors: williams t. Mult Scler Relat Disord. 2021 Oct;55:103190. doi: 10.1016/j.msard.2021.103190. Epub 2021 Aug 2. Mult Scler Relat Disord. 2021. PMID: 34365316

6

Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis: From the MS-STAT Randomized Controlled Trial.

Williams TE, Holdsworth KP, Nicholas JM, Eshaghi A, Katsanouli T, Wellington H, Heslegrave A, Zetterberg H, Frost C, Chataway J. Williams TE, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Jan 14;9(2):e1130. doi: 10.1212/NXI.0000000000001130. Print 2022 Mar. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35031587 Free PMC article. Clinical Trial.

7

Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study.

Williams T, Mishra R, Bharkhada B, Shields A, Dorsey R, Chataway J, Brownlee WJ. Williams T, et al. J Neurol Neurosurg Psychiatry. 2022 Mar 10;93(11):1229-30. doi: 10.1136/jnnp-2021-328340. Online ahead of print. J Neurol Neurosurg Psychiatry. 2022. PMID: 35273069 Free PMC article. No abstract available.

8

Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis.

Calvi A, Carrasco FP, Tur C, Chard DT, Stutters J, De Angelis F, John N, Williams T, Doshi A, Samson RS, MacManus D, Gandini Wheeler-Kingshott CA, Ciccarelli O, Chataway J, Barkhof F; MS SMART Investigators. Calvi A, et al. Among authors: williams t. Neurology. 2022 Apr 26;98(17):e1783-e1793. doi: 10.1212/WNL.0000000000200144. Epub 2022 Mar 11. Neurology. 2022. PMID: 35277438

9

The prognostic significance of early blood neurofilament light chain concentration and magnetic resonance imaging variables in relapse-onset multiple sclerosis.

Williams T, Heslegrave A, Zetterberg H, Miszkiel KA, Barkhof F, Ciccarelli O, Brownlee WJ, Chataway J. Williams T, et al. Brain Behav. 2022 Sep;12(9):e2700. doi: 10.1002/brb3.2700. Epub 2022 Aug 4. Brain Behav. 2022. PMID: 35925940 Free PMC article.

10

Optimising recruitment in clinical trials for progressive multiple sclerosis: observational analysis from the MS-SMART and MS-STAT2 randomised controlled trials.

Williams T, Alexander S, Blackstone J, De Angelis F, John N, Doshi A, Beveridge J, Braisher M, Gray E, Chataway J; MS-SMART and MS-STAT2 Investigators. Williams T, et al. Trials. 2022 Aug 9;23(1):644. doi: 10.1186/s13063-022-06588-z. Trials. 2022. PMID: 35945550 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,911 results

Search Page

Filters